TUCSON, Ariz., Aug. 3, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the new IVD configuration of its Accelerate PhenoTest® BC kit has been CE marked and is ...

BD (Becton, Dickinson and Co.) announced Aug. 15 a commercial collaboration under which the Franklin Lakes-based company will offer Accelerate Diagnostics Inc.’s rapid tests through its global sales ...

- In Patients Who Receive Ineffective Empirical Antibiotics for Blood Stream Infections (BSI), Use of AXDX Was Associated With Reduction in 30-Day Mortality - Interim Data From Multicenter Study ...

Sepsis is a potentially fatal response from the body to an infection, and 1.7 million Americans develop it each year. Obviously, it's of utmost importance for physicians to be able to rapidly diagnose ...

TUCSON, Ariz., April 21, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the sizeable release of new data presented by the company, its customers, and clinical experts during the ...

TUCSON, Ariz., Jan. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower ...

In response toreceivingFDA marketing authorization for two products, shares of Accelerate Diagnostics (NASDAQ: AXDX), a company focused onthe rapid diagnosis of infectious diseases, rose by 11% as of ...

The PhenoTest BC Kit demonstrated its effectiveness in significantly reducing the time to optimal therapy and to the first antibiotic intervention for treating bloodstream infections. Let's take a ...

Shares of Accelerate Diagnostics Inc AXDX, an in-vitro diagnostics company, spiked higher by more than 15 percent early Friday morning after the company provided an update relating to its Accelerate ...

The Accelerate Arc system is designed to leverage the breadth of the Bruker MBT-CA reference library to provide rapid ID. This, in conjunction with our future rapid phenotypic antibiotic ...

TUCSON, Ariz., March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m. Eastern Time to ...